The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.124.5.699

Schizophrenic patients followed longitudinally from an acute psychotic phase to a remission were rated as more depressed during the period following improvement of schizophrenic symptoms than during the hospital course as a whole. The period following remission of symptoms may be a period of relatively high risk of suicide in schizophrenic patients.

One patient treated with phenothiazines after a period of severe psychosis showed no elevation of 17-hydroxycorticosteroids during the depressed periods as compared with a preceding nonpsychotic and nondepressed period. 17-hydroxycorticosteroids were elevated during the psychotic phase both as compared with normal values and as compared with the remainder of the hospital stay.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.